Alessandro Gialluisi, Simona Costanzo, Maria Ilenia De Bartolo, Giovanni Veronesi, Matteo Renzi, Assuntina Cembalo, Alfonsina Tirozzi, Stefania Falciglia, Moreno Ricci, Americo Bonanni, Francesco Martone, Gaetano Zazzaro, Antonietta Pepe, Daniele Belvisi, Marco Mario Ferrario, Francesco Gianfagna, Chiara Cerletti, Maria Benedetta Donati, Stefania Massari, Alfredo Berardelli, Giovanni de Gaetano, Licia Iacoviello
{"title":"Prominent role of PM10 in the link between air pollution and incident Parkinson’s Disease","authors":"Alessandro Gialluisi, Simona Costanzo, Maria Ilenia De Bartolo, Giovanni Veronesi, Matteo Renzi, Assuntina Cembalo, Alfonsina Tirozzi, Stefania Falciglia, Moreno Ricci, Americo Bonanni, Francesco Martone, Gaetano Zazzaro, Antonietta Pepe, Daniele Belvisi, Marco Mario Ferrario, Francesco Gianfagna, Chiara Cerletti, Maria Benedetta Donati, Stefania Massari, Alfredo Berardelli, Giovanni de Gaetano, Licia Iacoviello","doi":"10.1038/s41531-025-00935-y","DOIUrl":null,"url":null,"abstract":"<p>Air pollution has been associated with Parkinson’s Disease (PD) risk, although this relationship remains unclear. We estimated yearly levels of exposure to ten air pollutants (period 2006–2018) in an Italian population cohort, the Moli-sani study (<i>N</i> = 24,325; ≥35 years; 51.9% women), and derived three principal components, testing their associations with incident PD risk over 23,841 participants (213 cases, median(IQR) follow-up 11.2(2.0) years). This revealed a statistically significant association of PC1 (explaining 38.2% of common variance, tagging PM10 levels), independent on sociodemographic, professional and lifestyles covariates (Hazard Ratio [95%CI] = 1.04[1.02–1.07]). The association was confirmed testing average PM10 levels during follow-up (18[13–24]% increase of PD risk per 1 μg/m<sup>3</sup> increase of PM10). Among different circulating markers, lipoprotein a explained a significant proportion of this association (2.8[0.9; 8.4]%). These findings suggest PM10 as a target to lower PD risk at the population level and a potential implication of lipoprotein a in PD etiology.</p>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"81 1","pages":""},"PeriodicalIF":6.7000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Parkinson's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41531-025-00935-y","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Air pollution has been associated with Parkinson’s Disease (PD) risk, although this relationship remains unclear. We estimated yearly levels of exposure to ten air pollutants (period 2006–2018) in an Italian population cohort, the Moli-sani study (N = 24,325; ≥35 years; 51.9% women), and derived three principal components, testing their associations with incident PD risk over 23,841 participants (213 cases, median(IQR) follow-up 11.2(2.0) years). This revealed a statistically significant association of PC1 (explaining 38.2% of common variance, tagging PM10 levels), independent on sociodemographic, professional and lifestyles covariates (Hazard Ratio [95%CI] = 1.04[1.02–1.07]). The association was confirmed testing average PM10 levels during follow-up (18[13–24]% increase of PD risk per 1 μg/m3 increase of PM10). Among different circulating markers, lipoprotein a explained a significant proportion of this association (2.8[0.9; 8.4]%). These findings suggest PM10 as a target to lower PD risk at the population level and a potential implication of lipoprotein a in PD etiology.
期刊介绍:
npj Parkinson's Disease is a comprehensive open access journal that covers a wide range of research areas related to Parkinson's disease. It publishes original studies in basic science, translational research, and clinical investigations. The journal is dedicated to advancing our understanding of Parkinson's disease by exploring various aspects such as anatomy, etiology, genetics, cellular and molecular physiology, neurophysiology, epidemiology, and therapeutic development. By providing free and immediate access to the scientific and Parkinson's disease community, npj Parkinson's Disease promotes collaboration and knowledge sharing among researchers and healthcare professionals.